HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?

Diabetes, Metabolic Syndrome and Obesity

Volumn 6, Issue , 2013, Pages 477-491

  Kowall, Bernd ^a   Rathmann, Wolfgang ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Diabetes mellitus; Diagnosis; Diagnostic criteria; Retinopathy

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; AREA UNDER THE CURVE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; ETHNICITY; HUMAN; HYPERTENSION; INCIDENCE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MICROALBUMINURIA; MICROANEURYSM; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PREDICTIVE VALUE; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SMOKING; YOUDEN INDEX;

EID: 84888622290     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S39093     Document Type: Review

References (47)

1. American Diabetes Association. Executive summary: Standards of medical care in diabetes-2012. Diabetes Care. 2012;35(Suppl 1):S4-S10.
2. International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-1334.
3. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation [webpage on the Internet]. Geneva: World Health Organization; 2011. Available from: http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/. Accessed October 1, 2013.
4. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1c. Diabetes Care. 2011;34 Suppl 2:S184-S190.
5. Dankner R, Bergman M, Danoff A, etal. The metabolic deterioration that antedates diabetes: personal trajectories of HbA(1c) and fasting glucose as early indicators and possible triggers for intervention. Diabetes Metab Res Rev. 2013;29(1):1-7.
6. 1c. J Intern Med. 2012;271(3):227-236.
7. 1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011. Diabet Med. 2012;29(11):1350-1357.
8. 1c for diagnosing diabetes mellitus. Amer J Med. 2011;124(5):395-401.
9. 1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes. 2001;50(12):2858-2863.
10. 1c levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care. 2008;31(10):1991-1996.
11. 1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010;87(3):415-421.
12. 1c by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007;30(10):2453-2457.
13. Mostafa SA, Khunti K, Srinivasan BT, Webb D, Gray LJ, Davies MJ. The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Res Clin Pract. 2010;90(1):100-108.
14. Sattar N, Preiss D. HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards. Diabetologia. 2012; 55(6):1564-1567.
15. McCance DR, Hanson RL, Charles MA etal. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ. 1994;308(6940): 1323-1328.
16. World Health Organization. HbA1c in the Diagnosis of Type 2 Diabetes: a Systematic Review. 2011. Geneva: World Health Organization. Available from: http://www.who.int/diabetes/publications/sys_rev_hba1c_web.pdf. Assessed July 24, 2013.
17. Santos-Oliveira R, Purdy C, da Silva MP, dos Anjos Carneiro-Leão AM, Machado M, Einarson TR. Haemoglobin A1c levels and subsequent cardiovascular disease in persons without diabetes: a meta-analysis of prospective cohorts. Diabetologia. 2011;54(6):1327-1334.
18. Sarwar N, Aspelund T, Eiriksdottir G, etal. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med. 2010;7(5): e1000278.
19. Selvin E, Ning Y, Steffes MW, etal. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes. 2011;60(1):298-305.
20. Sabanayagam C, Liew G, Tai ES etal. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia. 2009;52(7): 1279-1289.
21. Massin P, Lange C, Tichet J, etal; DESIR (Data From an Epidemiological Study on the Insulin Resistance Syndrome) Study Group. Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study. Arch Ophthalmol. 2011;129(2):188-195.
22. Colagiuri S, Lee CMY, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K; DETECT-2 Collaboration Writing Group. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care. 2011;34(1):145-150.
23. Engelgau MM, Thompson TJ, Herman WH, etal. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care. 1997; 20(5):785-791.
24. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20(7):1183-1197.
25. van Leiden HA, Dekker JM, Moll AC etal. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol. 2003;121(2):245-251.
26. Tsugawa Y, Takahashi O, Meigs JB, etal. New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy. Diabetes. 2012;61(12):3280-3284.
27. Tapp RJ, Zimmet PZ, Harper CA etal; AusDiab Study Group. Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract. 2006;73(3):315-321.
28. Wong TY, Liew G, Tapp RJ, etal. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet. 2008;371(9614):736-743.
29. Cho NH, Kim TH, Woo SJ, etal. Optimal HbA1c cutoff for detecting diabetic retinopathy. Acta Diabetol. Epub January 25, 2013.
30. Xin Z, Yuan MX, Li HX, etal. Evaluation for fasting and 2-hour glucose and HbA1c for diagnosing diabetes based on prevalence of retinopathy in a Chinese population. PLoS One. 2012;7(7):e40610.
31. Sarwar N, Gao P, Seshasai SR, etal; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-2222.
32. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glusose and incident cardiovascular events. A metaregression analysis of published data from 20studies of 95,783individuals followed for 12.4 years. Diabetes Care. 1999;22(2):233-240.
33. Gerstein HC. Glucose: a continuous risk factor for cardiovascular disease. Diabet Med. 1997;14(Suppl 3):S25-S31.
34. Selvin E, Steffes MW, Zhu H, etal. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9): 800-811.
35. Gunnlaugsdottir E, Halldorsdottir S, Klein R, etal. Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-R). Diabetologia. 2012;55(3):671-680.
36. Tsugawa Y, Mukamal KJ, Davis RB, Taylor WC, Wee CC. Should the hemoglobin A(1c) diagnostic cutoff differ between blacks and whites?: a cross-sectional study. Ann Intern Med. 2012;157(3):153-159.
37. Chamnan P, Simmons RK, Jackson R, Khaw KT, Wareham NJ, Griffin SJ. Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorization to individual interpretation of absolute risk. Diabetologia. 2011;54(2):291-299.
38. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW; Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002;25(10):1845-1850.
39. Lauritzen T, Sandbaek A, Skriver MV, Borch-Johnsen K. HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark. Diabetologia. 2011;54(6):1318-1326.
40. Skriver MV, Borch-Johnson K, Lauritzen T, Sandbaek A. HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark. Diabetologia. 2010;53(11):2328-2333.
41. Bower JK, Brancati FL, Selvin E. No ethnic differences in the association of glycated hemoglobin with retinopathy: the national health and nutrition examination survey 2005-2008. Diabetes Care. 2013;36(3): 569-573.
42. Twombly JG, Long Q, Zhu M, etal. Validity of the primary care diagnosis of diabetes in veterans in the southeastern United States. Diabetes Res Clin Pract. 2011;91(3):395-400.
43. Ito C, Maeda R, Ishida S, Harada H, Inoue N, Sasaki H. Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Diabetes Res Clin Pract. 2000;49(2-3): 181-186.
44. Miyazaki M, Kubo M, Kiyohara Y, etal; Hisayama study. Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia. 2004;47(8):1411-1415.
45. Cheng YJ, Gregg EW, Geiss LS, etal. Association of A1c and fasting plasma glucose levels with diabetic retinopathy prevalence in the US population: Implications for diabetes diagnostic thresholds. Diabetes Care. 2009;32(11):2027-2032.
46. Bongaerts BW, Rathmann W, Kowall B, etal. Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 Study. Diabetes Care. 2012;35(9):1891-1893.
47. Hernandez D, Espejo-Gil A, Rosa Bernal-Lopez MR, etal. Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population. BMC Nephrol. 2013;14(1):151.